169 related articles for article (PubMed ID: 15618043)
1. Use of angiotensin-converting enzyme inhibitors and variations in cognitive performance among patients with heart failure.
Zuccalà G; Onder G; Marzetti E; Monaco MR; Cesari M; Cocchi A; Carbonin P; Bernabei R;
Eur Heart J; 2005 Feb; 26(3):226-33. PubMed ID: 15618043
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease.
Berger AK; Duval S; Manske C; Vazquez G; Barber C; Miller L; Luepker RV
Am Heart J; 2007 Jun; 153(6):1064-73. PubMed ID: 17540211
[TBL] [Abstract][Full Text] [Related]
3. Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure: an observational study of treatment rates and clinical outcome.
Gotsman I; Rubonivich S; Azaz-Livshits T
Isr Med Assoc J; 2008 Mar; 10(3):214-8. PubMed ID: 18494235
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
5. A propensity score analysis of the impact of angiotensin-converting enzyme inhibitors on long-term survival of older adults with heart failure and perceived contraindications.
Ahmed A; Centor RM; Weaver MT; Perry GJ
Am Heart J; 2005 Apr; 149(4):737-43. PubMed ID: 15990761
[TBL] [Abstract][Full Text] [Related]
6. Age-related underutilization of angiotensin-converting enzyme inhibitors in older hospitalized heart failure patients.
Ahmed A; Allman RM; DeLong JF; Bodner EV; Howard G
South Med J; 2002 Jul; 95(7):703-10. PubMed ID: 12144075
[TBL] [Abstract][Full Text] [Related]
7. Tissue angiotensin-converting enzyme inhibitors for the prevention of cardiovascular disease in patients with diabetes mellitus without left ventricular systolic dysfunction or clinical evidence of heart failure: a pooled meta-analysis of randomized placebo-controlled clinical trials.
Saha SA; Molnar J; Arora RR
Diabetes Obes Metab; 2008 Jan; 10(1):41-52. PubMed ID: 18095949
[TBL] [Abstract][Full Text] [Related]
8. Use of valsartan for the treatment of heart-failure patients not receiving ACE inhibitors: a budget impact analysis.
Smith DG; Cerulli A; Frech FH
Clin Ther; 2005 Jun; 27(6):951-9. PubMed ID: 16117995
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin converting enzyme (ACE) inhibitors modulate the rate of progression of amnestic mild cognitive impairment.
Rozzini L; Chilovi BV; Bertoletti E; Conti M; Del Rio I; Trabucchi M; Padovani A
Int J Geriatr Psychiatry; 2006 Jun; 21(6):550-5. PubMed ID: 16642542
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin-converting enzyme inhibitors prescription is associated with longer survival among patients hospitalized for congestive heart failure who have preserved systolic function: a long-term follow-up study.
Grigorian Shamagian L; Roman AV; Ramos PM; Veloso PR; Bandin Dieguez MA; Gonzalez-Juanatey JR
J Card Fail; 2006 Mar; 12(2):128-33. PubMed ID: 16520261
[TBL] [Abstract][Full Text] [Related]
11. The perindopril in elderly people with chronic heart failure (PEP-CHF) study.
Cleland JG; Tendera M; Adamus J; Freemantle N; Polonski L; Taylor J;
Eur Heart J; 2006 Oct; 27(19):2338-45. PubMed ID: 16963472
[TBL] [Abstract][Full Text] [Related]
12. The impact of angiotensin-converting enzyme inhibitor therapy on the extracellular collagen matrix during left ventricular assist device support in patients with end-stage heart failure.
Klotz S; Danser AH; Foronjy RF; Oz MC; Wang J; Mancini D; D'Armiento J; Burkhoff D
J Am Coll Cardiol; 2007 Mar; 49(11):1166-74. PubMed ID: 17367660
[TBL] [Abstract][Full Text] [Related]
13. Correlates of cognitive impairment among patients with heart failure: results of a multicenter survey.
Zuccalà G; Marzetti E; Cesari M; Lo Monaco MR; Antonica L; Cocchi A; Carbonin P; Bernabei R
Am J Med; 2005 May; 118(5):496-502. PubMed ID: 15866252
[TBL] [Abstract][Full Text] [Related]
14. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
15. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
[TBL] [Abstract][Full Text] [Related]
16. Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition.
van de Wal RM; Plokker HW; Lok DJ; Boomsma F; van der Horst FA; van Veldhuisen DJ; van Gilst WH; Voors AA
Int J Cardiol; 2006 Jan; 106(3):367-72. PubMed ID: 16337046
[TBL] [Abstract][Full Text] [Related]
17. Improving practice patterns in heart failure through a national cardiological network: the case of ACE-inhibitors.
Porcu M; Opasich C; Scherillo M; Lucci D; De Maria R; Di Tano G; Maggioni AP;
Ital Heart J; 2002 Dec; 3(12):730-7. PubMed ID: 12611125
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin-converting enzyme inhibitors in patients with coronary artery disease and absence of heart failure or left ventricular systolic dysfunction: an overview of long-term randomized controlled trials.
Danchin N; Cucherat M; Thuillez C; Durand E; Kadri Z; Steg PG
Arch Intern Med; 2006 Apr; 166(7):787-96. PubMed ID: 16606817
[TBL] [Abstract][Full Text] [Related]
19. Effects of angiotensin-converting enzyme inhibitors (ACE i) on zinc metabolism in patients with heart failure.
Trasobares E; Corbatón A; González-Estecha M; Lopez-Colón JL; Prats P; Olivan P; Sánchez JA; Arroyo M
J Trace Elem Med Biol; 2007; 21 Suppl 1():53-5. PubMed ID: 18039498
[TBL] [Abstract][Full Text] [Related]
20. Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart Failure.
Lenzen MJ; Boersma E; Reimer WJ; Balk AH; Komajda M; Swedberg K; Follath F; Jimenez-Navarro M; Simoons ML; Cleland JG
Eur Heart J; 2005 Dec; 26(24):2706-13. PubMed ID: 16183692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
